title: How can human DAF and HRF20 prevent HAR in transgenic mice?
authors.affiliation: Department of Surgery II, Nagoya University School of Medicine, Japan.
authors.forename: C
authors.initials: C
authors.lastname: Koike
authors.forename: K
authors.initials: K
authors.lastname: Isobe
authors.forename: I
authors.initials: I
authors.lastname: Nakashima
authors.forename: H
authors.initials: H
authors.lastname: Okada
authors.forename: S
authors.initials: S
authors.lastname: Hayashi
authors.forename: I
authors.initials: I
authors.lastname: Yokoyama
authors.forename: H
authors.initials: H
authors.lastname: Takagi
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology; D000328:Adult; D000818:Animals; D015139:Blotting, Southern; D018958:CD55 Antigens / Q000096:biosynthesis / Q000276:immunology*; D018957:CD59 Antigens / Q000096:biosynthesis / Q000276:immunology*; D003165:Complement System Proteins / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D016133:Polymerase Chain Reaction; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000276:immunology; D014183:Transplantation, Heterologous / Q000276:immunology*
chemical_list: D000017:ABO Blood-Group System; D018958:CD55 Antigens; D018957:CD59 Antigens; D011994:Recombinant Proteins; D003165:Complement System Proteins